Institut

bitte auswählen

Thomas Joos
Dr. Thomas Joos
Diplom-Biochemiker
Stellvertretender Institutsleiter
Tel.: 07121 51530-844
Fax: 07121 51530-16

Werdegang mit den wichtigsten Stationen:

Seit 2013: Stellvertretender Institutsleiter, NMI
Seit 04/2008: 25% Position an der EDI GmbH für die Koordination öffentlich geförderter Projekte
Seit 01/2000: Abteilungsleiter Biochemie, NMI
Seit 04/1998: wissenschaftlicher Mitarbeiter, NMI
1994 – 1998: Wissenschaftler am Max Planck Institut für Entwicklungsbiologie,
Abteilung Zellbiologie, Tübingen
1994: Promotionsarbeit (Dr. rer. nat) am Max Planck Institut für Entwicklungsbiologie,
Abteilung Zellbiologie, Tübingen, (unter Prof. P. Hausen: "Integrin-alpha5 während der frühen Embryogenese von Xenopus laevis")
04 – 08 1988: Molekularbiologisches Praktikum an der “Brandeis University“, Abteilung Biochemie
(Prof. Andrew Szent-Györgyi), Waltham, Massachusetts, USA
1984 – 1990: Studium der Biochemie, Universität Tübingen

Dr. Joos ist wissenschaftlicher Berater für BioChipNet (www.biochipnet.de) und gehört zur Redaktion von "Drug Discovery Today", "Proteomics", "Molecular Biotechnology" and "Expert Review of Proteomics". Er ist Mitglied im Wissenschaftlichen Beirat des Plasma Proteome Institute in Washington, DC, USA und des AlbaNova VINN Excellence Centre for Protein Technology (ProNova) an der Königlich Technischen Hochschule (Royal Institute of Technology) in Stockholm, Schweden. Ebenso gehört er dem Wissenschaftlichen Beirat von Luminex Corporation, Austin, Texas, USA, von Rules Based Medicine Inc., Austin, Texas, USA und von Epitome Biosystems, Waltham, Massachusetts, USA an. Als geladener Redner, Berater und Vorsitzender nimmt Dr. Joos an allen wichtigen internationalen Biochip-Konferenzen teil. Er ist Autor vieler Veröffentlichungen, zuletzt in "Drug Discovery Today", "Proteomics" und "Trends in Biotechnology". Dr. Joos ist weltweit anerkannt als Experte und Meinungsführer im Bereich der Protein-Mikroarray-Technologien und ihrer Anwendungen.

Publikationen

Schelle, J., Hasler, L. M., Gopfert, J. C., Joos, T. O., Vanderstichele, H., Stoops, E., Mandelkow, E. M., Neumann, U., Shimshek, D. R., Staufenbiel, M., Jucker, M. Kaeser, S. A.
Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition
Alzheimers Dement. 2017 Jun;13(6):701-709. doi: 10.1016/j.jalz.2016.09.005. Epub 2016 Oct 14.

Brockmann, K., Schulte, C., Schneiderhan-Marra, N., Apel, A., Pont-Sunyer, C., Vilas, D., Ruiz-Martinez, J., Langkamp, M., Corvol, J. C., Cormier, F., Knorpp, T., Joos, T. O., Bernard, A., Gasser, T., Marras, C., Schule, B., Aasly, J. O., Foroud, T., Marti-Masso, J. F., Brice, A., Tolosa, E., Berg, D., Maetzler, W. (2017).
Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease
Eur J Neurol. 2017 Feb;24(2):427-e6. doi: 10.1111/ene.13223.

Treindl, F., Ruprecht, B., Beiter, Y., Schultz, S., Dottinger, A., Staebler, A., Joos, T. O., Kling, S., Poetz, O., Fehm, T., Neubauer, H., Kuster, B., Templin, M. F. (2016).
A bead-based western for high-throughput cellular signal transduction analyses
Nat Commun. 2016 Sep 23;7:12852. doi: 10.1038/ncomms12852.

Filomena, A., Beiter, Y., Templin, M. F., Joos, T. O., Schneiderhan-Marra, N., Poetz, O. (2015).
Bead-Based Peptide Arrays for Profiling the Specificity of Modification State-Specific Antibodies
Methods Mol Biol. 2015;1348:251-65. doi: 10.1007/978-1-4939-2999-3_22.

Wurster, T., Poetz, O., Stellos, K., Kremmer, E., Melms, A., Schuster, A., Nagel, E., Joos, T., Gawaz, M., Bigalke, B. (2013).
Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke
Platelets. 2013;24(7):560-5. doi: 10.3109/09537104.2012.746455. Epub 2012 Dec 5.

Potz, O., Schneiderhan-Marra, N., Henzler, T., Herget, T., Joos, T. O. (2012).
Receptor tyrosine kinase inhibitor profiling using bead-based multiplex sandwich immunoassays
Methods Mol Biol. 2012;795:191-202. doi: 10.1007/978-1-61779-337-0_13.

Templin, M. F., Poetz, O., Schwenk, J. M., Stoll, D., Joos, T. O. (2006).
Miniaturized Multiplexed Protein Binding Assays
Frontiers in Biochip Technology. W.-L. Xing and J. Cheng. Boston, MA, Springer US: 61-87.

Kempf, H., Olmer, R., Haase, A., Franke, A., Bolesani, E., Schwanke, K., Robles-Diaz, D., Coffee, M., Gohring, G., Drager, G., Potz, O., Joos, T., Martinez-Hackert, E., Haverich, A., Buettner, F. F., Martin, U., Zweigerdt, R. (2016).
Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells
Nat Commun. 2016 Dec 9;7:13602. doi: 10.1038/ncomms13602.

Blank, G., Welker, C., Haarer, J., Sterk, M., Nadalin, S., Yanez, V. A., Joos, T. O., Menrad, A., Snell, D., LaCorcia, G., Konigsrainer, A., Handgretinger, R., Schilbach, K. (2015).
Selective, efficient modulation of activated CD4+ alphabetaT cells by the novel humanized antibody GZ-alphabetaTCR targeting human alphabetaTCR
Bone Marrow Transplant. 2015 Mar;50(3):390-401. doi: 10.1038/bmt.2014.263. Epub 2014 Nov 17.

Aroner, S. A., Rosner, B. A., Tamimi, R. M., Tworoger, S. S., Baur, N., Joos, T. O., Hankinson, S. E. (2014).
Plasma matrix metalloproteinase 1, 3, and 7 levels and breast cancer risk in the Nurses' Health study
Cancer Causes Control. 2014 Dec;25(12):1717-23. doi: 10.1007/s10552-014-0462-7. Epub 2014 Sep 16.

Aroner, S. A., Rosner, B. A., Tamimi, R. M., Tworoger, S. S., Baur, N., Joos, T. O., Hankinson, S. E. (2015).
Plasma matrix metalloproteinase 2 levels and breast cancer risk
Cancer Epidemiol. 2015 Jun;39(3):321-7. doi: 10.1016/j.canep.2015.02.010. Epub 2015 Mar 19.

Gautier, J. C., Zhou, X., Yang, Y., Gury, T., Qu, Z., Palazzi, X., Leonard, J. F., Slaoui, M., Veeranagouda, Y., Guizon, I., Boitier, E., Filali-Ansary, A., van den Berg, B. H., Poetz, O., Joos, T., Zhang, T., Wang, J., Detilleux, P., Li, B. (2016).
Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin
Toxicol Appl Pharmacol. 2016 Jul 15;303:1-10. doi: 10.1016/j.taap.2016.04.012. Epub 2016 Apr 19.

Keller, R., Klein, M., Thomas, M., Drager, A., Metzger, U., Templin, M. F., Joos, T. O., Thasler, W. E., Zell, A., Zanger, U. M. (2016).
Coordinating Role of RXRalpha in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic Modeling
PLoS Comput Biol. 2016 Jan 4;12(1):e1004431. doi: 10.1371/journal.pcbi.1004431. eCollection 2016 Jan.

Albrecht, A., Rahmoune, H., Leedjarv, K., Knorpp, T., Joos, T., Stocki, P., Guest, P. C., Bahn, S. (2013).
Development of a novel assay for proprotein converting enzyme activity on a multiplex bead-based array system
Proteomics. 2013 Oct;13(20):2976-9. doi: 10.1002/pmic.201300060.

Groll, N., Petrikat, T., Vetter, S., Wenz, C., Dengjel, J., Gretzmeier, C., Weiss, F., Poetz, O., Joos, T. O., Schwarz, M., Braeuning, A. (2016).
Inhibition of beta-catenin signaling by phenobarbital in hepatoma cells in vitro
Toxicology. 2016 Aug 31;370:94-105. doi: 10.1016/j.tox.2016.09.018. Epub 2016 Sep 30.

Groll, N., Petrikat, T., Vetter, S., Colnot, S., Weiss, F., Poetz, O., Joos, T. O., Rothbauer, U., Schwarz, M., Braeuning, A. (2016).
Coordinate regulation of Cyp2e1 by beta-catenin- and hepatocyte nuclear factor 1alpha-dependent signaling
Toxicology. 2016 Mar 28;350-352:40-8. doi: 10.1016/j.tox.2016.05.004. Epub 2016 May 3.

Kropp, C., Kempf, H., Halloin, C., Robles-Diaz, D., Franke, A., Scheper, T., Kinast, K., Knorpp, T., Joos, T. O., Haverich, A., Martin, U., Zweigerdt, R., Olmer, R. (2016).
Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors
Stem Cells Transl Med. 2016 Oct;5(10):1289-1301. Epub 2016 Jul 1.

Schelle, J., Hasler, L., Gopfert, J. C., Joos, T. O., Vanderstichele, H., Stoops, E., Mandelkow, E. M., Neumann, U., Shimshek, D. R., Staufenbiel, M., Jucker, M., Kaeser, S. A. (2016).
Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition
Alzheimers Dement. 2016 Oct 14. pii: S1552-5260(16)32951-X. doi: 10.1016/j.jalz.2016.09.005.

Cheng, F., Twardowski, L., Fehr, S., Aner, C., Schaeffeler, E., Joos, T., Knorpp, T., Dorweiler, B., Laufer, S., Schwab, M., Torzewski, M. (2016).
Selective p38alpha MAP kinase/MAPK14 inhibition in enzymatically-modified LDL-stimulated human monocytes: implications for atherosclerosis
FASEB J. 2016 Nov 8. pii: fj.201600669R.

Brockmann, K., Apel, A., Schulte, C., Schneiderhan-Marra, N., Pont-Sunyer, C., Vilas, D., Ruiz-Martinez, J., Langkamp, M., Corvol, J. C., Cormier, F., Knorpp, T., Joos, T. O., Gasser, T., Schule, B., Aasly, J. O., Foroud, T., Marti-Masso, J. F., Brice, A., Tolosa, E., Marras, C., Berg, D., Maetzler, W. (2016).
Inflammatory profile in LRRK2-associated prodromal and clinical PD
J Neuroinflammation. 2016 May 24;13(1):122. doi: 10.1186/s12974-016-0588-5.

Groll, N., Kollotzek, F., Goepfert, J., Joos, T. O., Schwarz, M., Braeuning, A. (2016).
Phenobarbital inhibits calpain activity and expression in mouse hepatoma cells
Biol Chem. 2016 Jan 1;397(1):91-6. doi: 10.1515/hsz-2015-0223.

Posch, A., Groll, N., Sommersdorf, C., Joos, T. O., Poetz, O. (2015).
A Bead-Based Multiplex Sandwich Immunoassay to Assess the Abundance and Posttranslational Modification State of β-Catenin
Proteomic Profiling, Springer New York. 1295: 441-453.

Groll, N., Sommersdorf, C., Joos, T. O., Poetz, O. (2015).
A Bead-Based Multiplex Sandwich Immunoassay to Assess the Abundance and Posttranslational Modification State of beta-Catenin
Methods Mol Biol. 2015;1295:441-53. doi: 10.1007/978-1-4939-2550-6_31.

Weiß, F., Schnabel, A., Planatscher, H., van den Berg, B. H. J., Serschnitzki, B., Nuessler, A. K., Thasler, W. E., Weiss, T. S., Reuss, M., Stoll, D., Templin, M. F., Joos, T. O., Marcus, K., Poetz, O. (2015).
Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry
Sci. Rep. 5.

Planatscher, Hannes, Weiss, Frederik, Eisen, David, Zell, Andreas, Joos, Thomas, Poetz, Oliver (2014).
Identification of short terminal motifs enriched by antibodies using peptide mass fingerprinting
Bioinformatics first published online January 9, 2014 doi:10.1093/bioinformatics/btu009

Weiss, F., van den Berg, B. H., Planatscher, H., Pynn, C. J., Joos, T. O., Poetz, O. (2013).
Catch and measure-mass spectrometry-based immunoassays in biomarker research
Biochim Biophys Acta. 2013 Sep 21. pii: S1570-9639(13)00344-0. doi: 10.1016/j.bbapap.2013.09.010.

Heubach, Y., Planatscher, H., Sommersdorf, C., Maisch, D., Maier, J., Joos, T. O., Templin, M. F., Poetz, O. (2013).
From spots to beads-PTM-peptide bead arrays for the characterization of anti-histone antibodies
Proteomics. 2013 Mar;13(6):1010-5. doi: 10.1002/pmic.201200383.

Moskalev, E. A., Luckert, K., Vorobjev, I. A., Mastitsky, S. E., Gladkikh, A. A., Stephan, A., Schrenk, M., Kaplanov, K. D., Kalashnikova, O. B., Potz, O., Joos, T. O., Hoheisel, J. D. (2012).
Concurrent epigenetic silencing of wnt/beta-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
BMC Cancer. 2012 Jun 6;12:213. doi: 10.1186/1471-2407-12-213.

Schmohl, M., Schneiderhan-Marra, N., Baur, N., Hefner, K., Blum, M., Stein, G. M., Joos, T. O., Schmolz, M. (2012)
Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole blood
Int Immunopharmacol. 2012 Oct 24;14(4):722-728. doi: 10.1016/j.intimp.2012.10.010.

Volk, S., Schreiber, T. D., Eisen, D., Wiese, C., Planatscher, H., Pynn, C. J., Stoll, D., Templin, M. F., Joos, T. O., Potz, O. (2012)
Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis
Mol Cell Proteomics. 2012 Jul;11(7):O111.015438. Epub 2012 Apr 23.

Luckert, K., Gujral, T. S., Chan, M., Sevecka, M., Joos, T. O., Sorger, P. K., Macbeath, G., Potz, O. (2012)
A dual array-based approach to assess the abundance and posttranslational modification state of signaling proteins
Sci Signal. 2012 Jan 10;5(206):pl1. doi: 10.1126/scisignal.2002372.

Schwenk, J. M., Poetz, O., Zeillinger, R., Joos, T. (2012)
A Miniaturized Ligand Binding Assay for EGFR
International Journal of Proteomics 2012: 5.

Sauer, G., Schneiderhan-Marra, N., Muche, R., Koretz, K., Kazmaier, C., Kreienberg, R., Joos, T., Deissler, H. (2011)
Molecular indicators of non-sentinel node status in breast cancer determined in preoperative biopsies by multiplexed sandwich immunoassays
J Cancer Res Clin Oncol. 2011 Aug;137(8):1175-84. Epub 2011 Apr 24.

Bigalke, B., Potz, O., Kremmer, E., Geisler, T., Seizer, P., Puntmann, V. O., Phinikaridou, A., Chiribiri, A., Nagel, E., Botnar, R. M., Joos, T., Gawaz, M. (2011)
Sandwich Immunoassay for Soluble Glycoprotein VI in Patients with Symptomatic Coronary Artery Disease
Clin Chem. 2011 Jun;57(6):898-904. Epub 2011 Apr 7.

Luckert, K., Gotschel, F., Sorger, P. K., Hecht, A., Joos, T. O., Potz, O.
Snapshots of Protein Dynamics and Post-translational Modifications In One Experiment--{beta}-Catenin and Its Functions
Mol Cell Proteomics. 2011 May;10(5):M110.007377. Epub 2011 Mar 4.

Matheis, K., Laurie, D., Andriamandroso, C., Arber, N., Badimon, L., Benain, X., Bendjama, K., Clavier, I., Colman, P., Firat, H., Goepfert, J., Hall, S., Joos, T., Kraus, S., Kretschmer, A., Merz, M., Planatscher, H., Schneiderhan-Marra, N., et al. (2011)
A generic operational strategy to qualify translational safety biomarkers
Drug Discov Today. 2011 May 6.

Luckert, K., Goetschel, F., Sorger, P. K., Hecht, A., Joos, T. O., Poetz, O. (2011)
Snapshots of protein dynamics and posttranslational modifications in one experiment - [beta]-catenin and its functions
Mol Cell Proteomics. 2011 May;10(5):M110.007377. Epub 2011 Mar 4.

Planatscher, H., Supper, J., Poetz, O., Stoll, D., Joos, T., Templin, M. F., Zell, A. (2010)
Optimal selection of epitopes for TXP-immunoaffinity mass spectrometry
Algorithms Mol Biol. 2010 Jun 25;5:28.

Punyadeera, C., Schneider, E. M., Schaffer, D., Hsu, H. Y., Joos, T. O., Kriebel, F., Weiss, M., Verhaegh, W. F. (2012)
A biomarker panel to discriminate between systemic inflammatory response syndrome and sepsis and sepsis severity
J Emerg Trauma Shock. 2010 Jan;3(1):26-35.

Rimmele, S., Gierschik, P., Joos, T. O., Schneiderhan-Marra, N. (2010)
Bead-based protein-protein interaction assays for the analysis of Rho GTPase signaling
J Mol Recognit. 2010 Nov-Dec;23(6):543-50.

Hoeppe, S., Schreiber, T. D., Planatscher, H., Zell, A., Templin, M. F., Stoll, D., Joos, T. O., Poetz, O. (2010)
Targeting peptide termini - a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identification
Mol Cell Proteomics. 2010 Oct 20.

Yu, X., Schneiderhan-Marra, N., Joos, T. O. (2010)
Protein microarrays for personalized medicine
Clin Chem. 2010 Mar;56(3):376-87. Epub 2010 Jan 14.

Schneiderhan-Marra, N., Sauer, G., Kazmaier, C., Hsu, H. Y., Koretz, K., Deissler, H., Joos, T. O. (2010)
Multiplexed immunoassays for the analysis of breast cancer biopsies
Anal Bioanal Chem. 2010 Aug;397(8):3329-38. Epub 2010 Jul 18.

Schmohl, M., Rimmele, S., Potz, O., Kloog, Y., Gierschik, P., Joos, T. O., Schneiderhan-Marra, N. (2010)
Protein-protein-interactions in a multiplexed, miniaturized format a functional analysis of Rho GTPase activation and inhibition
Proteomics. 2010 Apr;10(8):1716-20.

Poetz, O., Henzler, T., Hartmann, M., Kazmaier, C., Templin, M. F., Herget, T., Joos, T. O. (2010)
Sequential multiplex analyte capturing for phospho-protein profiling
Mol Cell Proteomics mcp.M110.002709

Poetz, O., Henzler, T., Hartmann, M., Kazmaier, C., Templin, M. F., Herget, T., Joos, T. O. (2010)
Sequential multiplex analyte capturing for phospho-protein profiling
Mol Cell Proteomics. 2010 Nov;9(11):2474-81. Epub 2010 Aug 3

Hsu, H. Y., Joos, T. O., Koga, H. (2009)
Multiplex microsphere-based flow cytometric platforms for protein analysis and their application in clinical proteomics - from assays to results
Electrophoresis. 2009 Dec;30(23):4008-19.

Herget, T., Henzler, T., Hayes, S., Joos, T. (2009)
Array-Technologien für die Multiparameteranalytik von Proteomen
Pabst Science Publishers, 2008, p 3 - 15; ISBN 978-3-89967-461-3; www.pabst-publishers.de

Joos, T., Bachmann, J. (2009)
Protein microarrays: potentials and limitations
Front Biosci. 2009 Jan 1;14:4376-85.

Bigalke, B., Stellos, K., Stakos, D., Joos, T., Potz, O., Geisler, T., Bischofs, C., Kremmer, E., Kramer, B. F., Seizer, P., May, A. E., Lindemann, S., Gawaz, M. (2009)
Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome
Thromb Haemost. 2009 May;101(5):911-5.

Hsu, H. Y., Wittemann, S., Joos, T. O. (2008)
Miniaturized parallelized sandwich immunoassays.
Methods Mol Biol. 2007;428:247-62.

Hartmann, M., Roeraade, J., Stoll, D., Templin, M.F., Joos, T.O. (2009)
Protein microarrays for diagnostic assays.
Anal Bioanal Chem. 2009 Mar;393(5):1407-16. Epub 2008 Sep 20.

Hartmann, M., Sjödahl, J., Stjernström, M., Redeby, J., Joos, T., Roeraade, J. (2011)
Non-contact protein microarray fabrication using a procedure based on liquid bridge formation.
Anal Bioanal Chem. 2009 Jan;393(2):591-8. Epub 2008 Nov 21

Poetz, O., Hoeppe, S., Templin, M. F., Stoll, D., Joos, T. O. (2009)
Proteome wide screening using peptide affinity capture
Proteomics. 2009 Mar;9(6):1518-23.

Bigalke, B., Stellos, K., Weig, H. J., Geisler, T., Seizer, P., Kremmer, E., Potz, O., Joos, T., May, A. E., Lindemann, S., Gawaz, M. (2009)
Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS)
Basic Res Cardiol. 2009 May;104(3):352-7. Epub 2009 Feb 3.

Hartmann, M., Roeraade, J., Stoll, D., Templin, M. F., Joos, T. O. (2009)
Protein microarrays for diagnostic assays
Anal Bioanal Chem. 2009 Mar;393(5):1407-16. Epub 2008 Sep 20.

Stoll, D., Templin, M. F., Bachmann, J., Joos, T. O. (2005)
Protein microarrays: applications and future challenges
Curr Opin Drug Discov Devel. 2005 Mar;8(2):239-52.

Oehmig, A., Klotzbucher, A., Thomas, M., Weise, F., Hagner, U., Brundiers, R., Waldherr, D., Lingnau, A., Knappik, A., Kubbutat, M., H., Joos, T. O., Volkmer, H. (2008)
A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries
BMC Genomics. 2008 Sep 24;9:441.

Hartmann, M., Schrenk, M., Dottinger, A., Nagel, S., Roeraade, J., Joos, T. O., Templin, M. F. (2008)
Expanding assay dynamics: a combined competitive and direct assay system for the quantification of proteins in multiplexed immunoassays
Clin Chem. 2008 Jun;54(6):956-63. Epub 2008 Apr 24.

Sauer, G., Schneiderhan-Marra, N., Kazmaier, C., Hutzel, K., Koretz, K., Muche, R., Kreienberg, R., Joos, T., Deissler, H. (2008)
Prediction of Nodal Involvement in Breast Cancer Based on Multiparametric Protein Analyses from Preoperative Core Needle Biopsies of the Primary Lesion.
Clin Cancer Res. 2008 Jun 1;14(11):3345-3353.

Weinzierl, A. O., Maurer, D., Altenberend, F., Schneiderhan-Marra, N., Klingel, K., Schoor, O., Wernet, D., Joos, T., Rammensee, H. G., Stevanovic, S. (2008)
A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays
Cancer Res. 2008 Apr 1;68(7):2447-54.

Stoll, D., Bachmann, J., Templin, M.F., Joos, T.O. (2004)
Microarray technology: an increasing variety of screening tools for proteomic research.
DDT:Targets 3 (1) P. 24-31

Schneiderhan-Marra, N., Kirn, A., Döttinger, A., Templin, M., Sauer, G., Deissler, H., Joos, T.O. (2005)
Protein Microarrays - A Promising Tool for Cancer Diagnosis
Cancer Genomics & Proteomics Vol. 2, Issue 1, p. 37-42

Kriebel, F., Wittemann, S., Hsu, H. Y., Joos, T., Weiss, M., Schneider, E. M. (2006)
Caspase-3 activation, Bcl-2 contents, and soluble FAS-ligand are not related to the inflammatory marker profile in patients with sepsis and septic shock
Ann N Y Acad Sci Vol. 1090, p. 168-76

Kricka, L. J., Master, S. R., Joos, T.O., Fortina, P. (2006)
Current perspectives in protein array technology
Ann Clin Biochem Vol. 43, Issue PT 6, p. 457-67.

Woehrle, T., Du, W., Goetz, A, Hsu, H.Y., Joos, T.O., Weiss, M., Bauer, U., Brueckner, U.B., Marion Schneider, E. (2008)
Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans
Cytokine. 2008 Mar;41(3):322-9. Epub 2008 Jan 30.

Hsu, H. Y., Wittemann, S., Schneider, E.M., Weiss, M., Joos, T.O. (2008)
Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases
Med Eng Phys. 2008 Oct;30(8):976-83. Epub 2008 Mar 3.

Joos, T., Kroeger, P. (2008)
New frontiers in microarray technology development
Curr Opin Biotechnol, Vol. 19, Issue 1, p. 1-3

Joos, T. (2004)
Protein microarray technology
Expert Rev Proteomics. 2004 Jun;1(1):1-3.

Templin, M. F., Stoll, D., Bachmann, J., Joos, T. O. (2004)
Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?
Comb Chem High Throughput Screen. 2004 May;7(3):223-9.

Templin, M. F., Stoll, D., Schwenk, J. M., Pötz, O., Kramer, S., Joos, T. O. (2003)
Protein microarrays: promising tools for proteomic research
Proteomics. 2003 Nov;3(11):2155-66.

Poetz, O., Schwenk, J. M., Kramer, S., Stoll, D., Templin, M. F., Joos, T. O. (2005)
Protein microarrays: catching the proteome.
Mech Ageing Dev. 2005 Jan;126(1):161-70.

Poetz, O., Ostendorp, R., Brocks, B., Schwenk, J. M., Stoll, D., Joos, T. O., Templin, M. F. (2005)
Protein microarrays for antibody profiling: Specificity and affinity determination on a chip.
Proteomics. 2005 Jun;5(9):2402-11.

Bodovitz, S., Joos, T., Bachmann, J. (2005)
Protein biochips: the calm before the storm.
Drug Discov Today 10, 283-287.

Bodovitz, S., Joos, T. (2004)
The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets.
Trends Biotechnol. 2004 Jan;22(1):4-7.

Joos, T.O., Pawlak, M., Templin, M., Stoll, D. (2006)
Protein Microarrays - Neue Systeme für die Proteomforschung
GIT Labor-Fachzeitschrift 10, page 890-892.

Joos, T. O., Berger, H. (2006)
The long and difficult road to the diagnostic market: protein microarrays.
Drug Discov Today. 2006 Nov;11(21-22):959-61. Epub 2006 Oct 2.

Hartmann, M., Toegl, A., Kirchner, R., Templin, M.F., Joos , T. O. (2006)
Increasing robustness and sensitivity of protein microarrays through microagitation and automation.
Anal Chim Acta. 2006 Mar 30;564(1):66-73. Epub 2006 Feb 21.

Wilding, P., Joos, T., Kricka, L.J., Shi, L. (2006)
Guidelines for terminology for microtechnology in clinical laboratories.
Pure Appl. Chem., Vol. 78, No. 3, page 677-684.

zurück